The US Food and Drug Administration (FDA) has cleared Grifols' investigational new drug (IND) application to initiate a Phase II trial of GRF312 Ophthalmic Solution, an immunoglobulin (IG) eye drop, ...
TheraTears (R) is an ophthalmologist created brand and offers a family of dry eye solutions that restore eyes' natural balance. Beginning February 2026, TheraTears (R) Eyelid Cleansing Wipes and ...
Please provide your email address to receive an email when new articles are posted on . Orasis Pharmaceuticals has submitted a new drug application to the FDA for CSF-1, its investigational eye drop ...
FARMINGTON HILLS, Mich., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing ...
When you have a migraine attack, you want fast, effective relief. But with a complex neurological condition like migraine disease, relief isn’t always simple. Although several medications can reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback